Reperfusion After Thrombolytic Therapy in Ischemic Stroke Measured by Single‐Photon Emission Computed Tomography
暂无分享,去创建一个
[1] B. Siesjö,et al. Thresholds in cerebral ischemia - the ischemic penumbra. , 1981, Stroke.
[2] T. Olsen,et al. A Dynamic Concept of Middle Cerebral Artery Occlusion and Cerebral Infarction in the Acute State Based on Interpreting Severe Hyperemia as a Sign of Embolic Migration , 1984, Stroke.
[3] R. Crowell,et al. Selective Necrosis and Total Necrosis in Focal Cerebral ischemia. Neuropathologic Observations on Experimental Middle Cerebral Artery Occlusion in the Macaque Monkey , 1984, Journal of neuropathology and experimental neurology.
[4] P F Sharp,et al. Technetium-99m HM-PAO stereoisomers as potential agents for imaging regional cerebral blood flow: human volunteer studies. , 1986, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[5] W Lang,et al. Initial experience with technetium-99m HM-PAO brain SPECT. , 1987, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[6] Alan C. Evans,et al. The effect of spontaneous reperfusion on metabolic function in early human cerebral infarcts , 1987, Annals of neurology.
[7] S. Hasselbalch,et al. Quantitative Measurements of Cerebral Blood Flow Using SPECT and [99mTc]-d,l-HM-PAO Compared to Xenon-133 , 1988, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[8] G. Lenzi,et al. Clinical and instrumental evaluation of patients with ischemic stroke within the first six hours , 1989, Journal of the Neurological Sciences.
[9] M. Fujishima,et al. Hemorrhagic transformation in cerebral embolism. , 1989, Stroke.
[10] V Hachinski,et al. The Canadian Neurological Scale , 1989, Neurology.
[11] J. Mountz,et al. Prognostication of recovery following stroke using the comparison of CT and technetium-99m HM-PAO SPECT. , 1990, Journal of Nuclear Medicine.
[12] M. Limburg,et al. Thrombolysis with recombinant tissue plasminogen activator in acute ischemic stroke: evaluation with rCBF‐SPECT , 1991, Acta neurologica Scandinavica.
[13] J. Marler,et al. Urgent Therapy for Stroke: Part II. Pilot Study of Tissue Plasminogen Activator Administered 91-180 Minutes From Onset , 1992, Stroke.
[14] A. Yamadori,et al. Intravenous recombinant tissue plasminogen activator in acute carotid artery territory stroke , 1992, Neurology.
[15] J. Broderick,et al. Urgent Therapy for Stroke: Part I. Pilot Study of Tissue Plasminogen Activator Administered Within 90 Minutes , 1992, Stroke.
[16] Transcranial Doppler Sonography Monitoring of Local Intra‐arterial Thrombolysis in Acute Occlusion of the Middle Cerebral Artery , 1992, Stroke.
[17] C. Weiller,et al. Type and extent of hemispheric brain infarctions and clinical outcome in early and delayed middle cerebral artery recanalization , 1992, Neurology.
[18] W. Hacke,et al. Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke , 1992, Annals of neurology.
[19] Intra‐arterial streptokinase in acute ischaemic stroke; A pilot study , 1993, The Medical journal of Australia.
[20] G. Marchal,et al. PET imaging of cerebral perfusion and oxygen consumption in acute ischaemic stroke: relation to outcome , 1993, The Lancet.
[21] N. Lassen,et al. Hyperfixation of HMPAO in subacute ischemic stroke leading to spuriously high estimates of cerebral blood flow by SPECT. , 1993, Stroke.